Showing results (1-10 of 1,075) with videos related to
Sort By:
Pageof 108
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivoM S Runge, C Bode, G R Matsueda, et al.Biochemistry|February 23, 1988
Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitroM S Runge, C Bode, G R Matsueda, et al.Japanese Circulation Journal|April 1, 1990
Antibody-targeted thrombolytic agentsE Haber, T Quertermous, G R Matsueda, et al.The Journal of Biological Chemistry|August 5, 1987
Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrinC Bode, M S Runge, J B Newell, et al.Bioconjugate Chemistry|July 1, 1990
Antibody-directed fibrinolysis: a bispecific (Fab')2 that binds to fibrin and tissue plasminogen activatorM S Runge, C Bode, C E Savard, et al.Journal of Molecular and Cellular Cardiology|April 1, 1987
Thrombolysis by a fibrin-specific antibody Fab'-urokinase conjugateC Bode, M S Runge, J B Newell, et al.The Journal of Biological Chemistry|January 15, 1989
Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activatorC Bode, M S Runge, E E Branscomb, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990
Synergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasminG L Reed, G R Matsueda, E HaberThrombosis and Haemostasis|September 7, 1992
Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrinG L Reed, G R Matsueda, E HaberCirculation|July 1, 1990
Inhibition of clot-bound alpha 2-antiplasmin enhances in vivo thrombolysisG L Reed, G R Matsueda, E HaberPageof 108